Page last updated: 2024-09-04

moxifloxacin and ellipticine

moxifloxacin has been researched along with ellipticine in 2 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(ellipticine)
Trials
(ellipticine)
Recent Studies (post-2010) (ellipticine)
3,1575521,6904540178

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)ellipticine (IC50)
Cytochrome P450 1A1Homo sapiens (human)0.0193
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.2
DNA topoisomerase 2-alphaHomo sapiens (human)3.3

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Trawneh, SA; Alfieri, RR; Cavazzoni, A; El-Abadelah, MM; Incerti, M; Kamal, MR; Petronini, PG; Vicini, P; Zahra, JA; Zani, F1
Al-Taweel, SA; Al-Trawneh, SA; Cavazzoni, A; El-Abadelah, MM; Incerti, M; Vicini, P; Zahra, JA; Zani, F1

Other Studies

2 other study(ies) available for moxifloxacin and ellipticine

ArticleYear
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents.
    Bioorganic & medicinal chemistry, 2010, Aug-15, Volume: 18, Issue:16

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line; Cell Line, Tumor; DNA Gyrase; DNA Topoisomerase IV; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Topoisomerase II Inhibitors

2010
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Thienopyridines; Topoisomerase II Inhibitors

2011